Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · IEX Real-Time Price · USD
2.330
-0.070 (-2.92%)
At close: May 31, 2024, 4:00 PM
2.320
-0.010 (-0.43%)
After-hours: May 31, 2024, 7:16 PM EDT
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $285.10 million as of May 31, 2024. Its market cap has decreased by -66.36% in one year.
Market Cap
285.10M
Enterprise Value
135.03M
1-Year Change
-66.36%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $285.10M, a decrease of -10.06%. That is a compound annual growth rate of -1.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 285.10M | -2.93% |
May 30, 2024 | 293.70M | 2.16% |
May 29, 2024 | 287.50M | -2.11% |
May 28, 2024 | 293.70M | 0.86% |
May 24, 2024 | 291.20M | -3.64% |
May 23, 2024 | 302.20M | -3.91% |
May 22, 2024 | 314.50M | -1.90% |
May 21, 2024 | 320.60M | -5.40% |
May 20, 2024 | 338.90M | 1.47% |
May 17, 2024 | 334.00M | 5.80% |
May 16, 2024 | 315.70M | 0.38% |
May 15, 2024 | 314.50M | -1.53% |
May 14, 2024 | 319.40M | -0.37% |
May 13, 2024 | 320.60M | -3.32% |
May 10, 2024 | 331.60M | 9.95% |
May 9, 2024 | 301.60M | -26.87% |
May 8, 2024 | 412.40M | -3.55% |
May 7, 2024 | 427.60M | 0.71% |
May 6, 2024 | 424.60M | 1.17% |
May 3, 2024 | 419.70M | 2.97% |
May 2, 2024 | 407.60M | -0.29% |
May 1, 2024 | 408.80M | 6.32% |
Apr 30, 2024 | 384.50M | 0.31% |
Apr 29, 2024 | 383.30M | 7.49% |
Apr 26, 2024 | 356.60M | 3.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sharecare | 295.11M |
Poseida Therapeutics | 289.90M |
CorMedix | 289.64M |
Viemed Healthcare | 287.66M |
Sera Prognostics | 285.17M |
Pulmonx | 281.41M |
Rani Therapeutics Holdings | 277.31M |
Black Diamond Therapeutics | 268.89M |